Canada Inhalation Anesthesia Market Size & Outlook
Canada inhalation anesthesia market, 2018-2030 (US$M)
Related Markets
Canada inhalation anesthesia market highlights
- The Canada inhalation anesthesia market generated a revenue of USD 63.3 million in 2022 and is expected to reach USD 138.7 million by 2030.
- The Canada market is expected to grow at a CAGR of 10.3% from 2023 to 2030.
- In terms of segment, sevoflurane was the largest revenue generating drug in 2022.
- Isoflurane is the most lucrative drug segment registering the fastest growth during the forecast period.
Inhalation anesthesia market data book summary
| Market revenue in 2022 | USD 63.3 million |
| Market revenue in 2030 | USD 138.7 million |
| Growth rate | 10.3% (CAGR from 2022 to 2030) |
| Largest segment | Sevoflurane |
| Fastest growing segment | Isoflurane |
| Historical data | 2016 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sevoflurane, Desflurane, Isoflurane |
| Key market players worldwide | Baxter International Inc, AbbVie Inc, Fresenius SE & Co KGaA, Sandoz Group AG ADR, Piramal Enterprises, Halocarbon Products Corporation, Lunan Pharmaceutical Group |
Other key industry trends
- In terms of revenue, Canada accounted for 5.2% of the global inhalation anesthesia market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. inhalation anesthesia market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 138.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Inhalation Anesthesia Market Scope
Inhalation Anesthesia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada inhalation anesthesia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inhalation anesthesia market will help companies and investors design strategic landscapes.
Sevoflurane was the largest segment with a revenue share of 63.51% in 2024. Horizon Databook has segmented the Canada inhalation anesthesia market based on sevoflurane, desflurane, isoflurane covering the revenue growth of each sub-segment from 2018 to 2030.
The Canada inhalation anesthesia market is experiencing steady growth, driven by increasing surgical procedures and advancements in anesthesia technologies.
The prevalence of cancer & respiratory diseases and the rising number of outpatient surgeries further fuel demand.
Lung, breast, colorectal, and prostate cancers are projected to account for 46% of these diagnoses, which is expected to drive the number of surgical procedures in the country.
Reasons to subscribe to Canada inhalation anesthesia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada inhalation anesthesia market databook
-
Our clientele includes a mix of inhalation anesthesia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada inhalation anesthesia market , including forecasts for subscribers. This country databook contains high-level insights into Canada inhalation anesthesia market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada inhalation anesthesia market size, by drug, 2018-2030 (US$M)
Canada Inhalation Anesthesia Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
